2 active not recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 2, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow JS207: new trials by email Literature Review of JS207 trials Research Report on JS207
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors 7MW3711, JS207, Cisplatin - Solid Tumor | Phase 1 / Phase 2 | Recruiting | Mabwell (Shanghai) Bioscience Co., Ltd. | 280 | 2026-02-11 | 2026-03-12 |
| Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors WJ47156, JS001+Bevacizumab, JS207 - Advanced Malignant Solid Tumors | Phase 1 | Active not recruiting | Shanghai Junshi Bioscience Co., Ltd. | 59 | 2024-10-23 | 2026-07-07 |
| The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor JS207 - Advanced Malignant Tumor | Phase 1 | Active not recruiting | Shanghai Junshi Bioscience Co., Ltd. | 98 | 2023-09-26 | 2026-07-02 |
Shanghai Junshi Bioscience Co., Ltd. (2) · Mabwell (Shanghai) Bioscience Co., Ltd. (1)
China (3) · Australia (1)